AGMB NASDAQ · Healthcare · FY 2025-12-31

Agomab Therapeutics NV

Back to NASDAQ
0.03.16.19.212.2ABVfair 2.10buy ≤ 0.73EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 11.30 EUR
0.03.56.910.413.9ABVfair 2.39buy ≤ 0.84EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 12.87 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in EURUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4
Price
11.30212.870 EURUSD *
Market cap
550.8M627.2M EURUSD *
P / B
4.21
P / E
—
EPS
-1.283-1.461
DPS / yield
— (0.0%)
NAV / share
2.0972.387
Graham number
—
Z'' score
3.82
Piotroski F
2 / 9
Beneish M
—
ROIC vs WACC
-124.3% vs 11.0%

* Listed in USD — the pipeline states price and all valuations in the filing currency EUR (fx 0.88 EUR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.